hybrid PSMA clinical trials

99mTechnetium and Cyanine-5 (HybriD) Prostate Specific Membrane Antigen (PSMA) Tracer-gUided Surgery in ProstAte Cancer - a FeasibiLity Study (DUAL study)

This study looks at a new way to help surgeons find prostate cancer more easily during operations. It uses a special tracer that lights up cancer cells. This could help surgeons remove all the cancer and improve treatment for men with prostate cancer.